Latest News

FRIULCHEM FIRMA UN ACCORDO PRELIMINARE VINCOLANTE PER L’ACQUISTO DI UN RAMO DI AZIENDA PRODUTTIVO IN FRANCIA

Friulchem announces it has obtained UNI EN ISO 9001:2015 certification for Research and Development and third party production of products containing active pharmaceutical ingredients and complementary feeds for veterinary use, as well as for the Development of technical/regulatory dossiers and marketing of pharmaceutical products for human use.

CS_Friulchem Certificazioni ISO eng

Friulchem Spa is the beneficiary of financing from the POR FESR 2014-2020 Call. Activity 2.3.c.1 “Finance for companies for the adoption of prevention and protection measures for safety in the workplace” – DGR 993/2020 with a project entitled INVESTMENT TO SUPPORT BUSINESS CONTINUATION RELATING TO THE COVID-19 HEALTH EMERGENCY, with financial support from the European Union, the Italian Republic and the Friuli Venezia Giulia Autonomous Region.

The project covers the purchase of individual PPE to ensure maximum safety for workers, as well as other unspecified equipment such as hand sanitiser stations and plexiglass screens. In addition, Friulchem Spa has engaged a specialist cleaning company to sanitise its work spaces, as well as a health and safety consultant to put in place all necessary procedures and carry out related employee training. In order to guarantee the highest possible safety standards, the company has rented premises near its headquarters in order to ensure greater social distancing between employees, adapting the building to bring it in line with the new safety measures. With a view to enhancing its digital capability, Friulchem also intends to develop a new website with an e-commerce platform for a new product developed by the company, in order to be available to customers at all times.

Main objectives of the project:

• Purchase of PPE and other equipment to guarantee employee safety in the workplace
• Internal reorganisation of the Vivaro site to guarantee safe continuity of production following the Covid-19 pandemic
• Enhancement of the company’s digital capability

The project was approved with allowable expenses of €56,601.00 of which we were granted a contribution of €28,300.50.

Friulchem S.p.A. is pleased to announce that starting in the first half of 2021 it will start marketing in Italy its own line of additives for feed used in the nutrition of so-called food-producing animals.

Feed additives are an important segment in animal nutrition and are used to meet the needs of certain nutrients and to increase the yield of healthy animals.

CS_Friulchem Additivi def_en

Friulchem Spa is the beneficiary of financing from the POR FESR 2014-2020 Call. Activity 2.3.b.3 “Investment aids and reorganisation and restructuring of PMIs – Support for the introduction of services and innovative technology relating to ICT in the Friulian Dolomites” – Call DGR 757/2018 with a project entitled INNOVATIVE LABORATORY ANALYSIS SOFTWARE TO ENABLE TRACEABILITY OF OPERATIONS, with the financial support from the European Union, the Italian Republic and the Friuli Venezia Giulia Autonomous Region.

The project comprises the purchase, installation and acceptance of new OpenLab 2.2 software. Agilent. This software is used to control the two Agilent 1100 and 1200 Series HPLC (high resolution liquid chromatography) instruments used in the company’s QC laboratory.

Main objectives of the project:

• To enhance machine performance;
• To add important functionality to our machines;
• To reduce data analysis time and enhance data processing activity;
• To enable traceability of operator activity in order to achieve a more structured, precise organisation of work.

The project was approved with allowable expenses of €14,261.20 of which we were granted a contribution of €11,408.96.

Friulchem will be present at the third edition of the China International Import Expo (CIIE), planned to be held at the Shanghai National Exhibition and Convention Centre (NECC) November 5-10, 2020.

Established by the Ministry of Commerce of the People's Republic of China and the Shanghai Municipal Government, with the support of Chinese institutions and international organizations, CIIE presents itself as the first fair in China dedicated to the import of products and services promoted by foreign exhibitors.

The company will present Suppleo, the range of high-quality complementary pet foods for dogs and cats based on Italian Fc-Cubes® technology patented by Friulchem.

CS_Friulchem CIIE def_eng

Suppleo is pleased to announce an extension to its product range. The current offering will be enriched with new, specially-developed lines of dietary supplements and accessories for pets, all distinguished by the care that’s synonymous with Suppleo.

Suppleo_ampliamento gamma_eng-GB

The new range of Suppleo complementary feed - aimed at preserving the mobility of cats and dogs - is now available on Amazon.

Joint EN

Part of the new Suppleo line for canine and feline health, a line dedicated to urinary tract health.

Read more:

Suppleo_Urinary_EN

Friulchem participates in the Virtual Edition of the Mid & Small Summer, an event organized by Virgilio Lab.

CS_Friulchem_Mid Small Virtual SUMMER 2020 DEF_EN

Part of the new Suppleo line, available on Amazon, we present an odour neutralizer for application in spaces frequented by dogs and cats.

Suppleo_MyspaceEN

For Friulchem, research and development in drug delivery plays a fundamental role ", says our CEO Disma Giovanni Mazzola, in an interview with Market Insight.

RS 20.07.2020_Market Insight R&D - ENG

Friulchem S.p.A. is pleased to announce that it has obtained authorization of a new patent application in France for chewable tablets, soon to be extended to other EU and non-EU countries.

Suppleo is the new Italian brand of high-quality complementary feed, with different product lines for specific needs, making its debut on the market choosing the online sales channel.

Read more: CS Suppleo Immune System

Friulchem is ready to seize every future opportunity in the animal health sector, which at this time presents excellent growth prospects. This is what Disma Giovanni Mazzola, CEO of Friulchem, declared when asked by MF Dow Jones.

Read the complete article: RS 24.06.2020 - MF Dow Jones_EN

Friulchem ​​purchased 13% of the capital of Pharmabbie last March, an American company specialized in the development of veterinary drugs to be distributed in the US market through FC-CUBE technology. 

Market Insight Pharmabbie

Read the interview of Disma Giovanni Mazzola, Friulchem CEO, released to EconomyMag.

Fore more information click here.

Read the interview of Disma Giovanni Mazzola, Friulchem CEO, released to Market Insight on Vet Business Unit.

Fore more information Market Insight veterinary.

After the ordinary shareholders' meeting of Friulchem ​​for the approval of the 2019 Financial Statements, the CEO Disma Giovanni Mazzola gave Market Insight a comment on these first months of 2020.

https://marketinsight.it/2020/04/24/friulchem-aim-da-inizio-2020-importanti-operazioni-per-continuare-nel-nostro-percorso-di-crescita/?mktins=au

Friulchem ​​brings Italian quality to China, obtaining from the Chinese Ministry of Agriculture, the registration of a veterinary supplement formulated and produced at its Vivaro plant.

New registration in China

Friulchem S.p.A. (AIM: FCM), in compliance with the informative obligations provided for by art. 17 of the AIM Italia Companies Regulations, releases the calendar of company events relative to the 2020 year.

Calendar 2020.

Friulchem obtained from Regione FVG the renewal of Vivaro's Applied Research Laboratory accreditation as a highly skilled facility in the veterinary and human generic drug R&D field.

Our new website is online! Discover our new line Suppleo especcially formulated for your pets.

https://suppleo.life/

The new range of complentary pet foods for dogs and cats based on Italian FC-CUBE® technology patented by Friulchem S.p.A.

Friulchem S.p.A. (AIM: FCM), an innovative SME and one of the leading Italian operators active at an international level in research and development and production for third parties (CDMO) of semi-finished and finished products containing active pharmaceutical ingredients, food supplements, with particular specialization in drug delivery , for the veterinary sector, as well as in the development of dossiers for generic drugs for human use and / or consumption, presents Suppleo, the new line of complementary feeds for dogs and cats, based on the Italian technology FC-CUBE© patented by Friulchem.

Download the press release (Italian only)

Friulchem Spa is the benificiary of financing from the POR FESR 2014-2020 Call. Activity 1.3.b “- Call DGR 1489/2017 with a project entitled SMART CLOT, with financial support from the European Union, the Italian Republic and the Friuli Venezia Giulia Autonomous Region.

The R&D project, carried out by establishing a Temporary Non-Profit Association (ATS) between our company and Sedicidodici Srl and the Center for Cancer Research (CRO) of Aviano, aims to develop an innovative diagnostic tool for "ex vivo" assessment of thrombotic-hemorrhagic potential in individuals with cardiovascular and oncological diseases. Automation, industrialization and clinical validation. As part of the Project, Friulchem will participate in the development of a non-negligible aspect of the system, concerning the support activities necessary for the development of single-use devices that form the strategic part of the system.

Main objectives of the project:

• Experiment, produce and ultimately clinically validate the Smart Clot diagnostic device;
• Create a low-cost automated device that can be introduced into clinical hospital environments.

The project was approved with allowable expenses of € 138,977.50 of which we were granted a contribution of € 41,367.52.

All colours, colours all! 

China International Beauty Expo (CIBE), is the largest beauty industry platform in China. 

We had a great experience last week in Shanghai, and we were awarded the Most Potential Brand Award.

Friulchem is honoured to take part in the new event "Pets in The City" next October in Milan.

Pets in the City will be an innovative event, with no parallel in its field.

A significant location, off-site activities and a constant thread linking all its contents will project information and training at all levels in deciding to buy and/or adopt a pet and in managing all the implications.

For the first time in Italy and in the best possible location, the city of Milan is about to host the Milano Pet Week, a week of meetings, playful and recreational activities and events designed to raise awareness, provide stimuli and information, increase the activities of the exhibitors taking part in the fair, achieve visibility with the general public and break out of the standards of the classical trade fair.

Download here the presentation and come to visit us!

We are pleased to report that an IQNet recognized certificate has issued for Friulchem S.p.A.
Also, this certificate is another significant achievement for our company as evidence of our ongoing commitment. 

We are pleased to report that Accreditation certificate of foreign animal drug manufacturer for Friulchem S.p.A. was issued on 12 October 2018.
This certificate is an important milestone for our company and represents a serious commitment to continuous improvement as we proceed along our path.  

CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 45,000 visiting pharma professionals over three days. 

Every sector of the pharmaceutical market is represented under one roof, this year in Madrid. Attending CPhI Worldwide is an effective way to establish new business relationships, meet with global partners and stay updated on the latest industry trends.

Friulchem S.p.A. will be exhibiting at CPhI Worldwide in Madrid from October 9-11, booth 4K32. 

We would welcome the opportunity to meet to learn about your business and discuss ways we may be able collaborate to advance your developments and manufacturing goals.

Contact us for scheduling a meeting.

Today, the association Unione Industriali Pordenone has published an article on Friulchem S.p.A. In their section "Imprese in evidenza", they talk about our company and our future projects.

Read here.

Friulia sostiene il consolidamento finanziario di Friulchem, azienda specializzata nella trasformazione di principi attivi per la produzione di farmaci e medicinali generici in ambito umano e veterinario per conto terzi. Con un intervento di private equity del valore di 1,9 milioni di Euro, Friulia consentirà l’incremento del giro d’affari della realtà di Vivaro, grazie agli investimenti in R&D per lo sviluppo di nuovi prodotti e per l’ampiamento della linea di produzione previsti dal piano industriale 2017-20.

Per leggere l'articolo completo apparso sul Friuli: http://www.ilfriuli.it/articolo/Economia/Friulia_investe_nello_sviluppo_di_Friulchem/4/183492

In the next forthcoming CPhI China, you will be able to discover more on Evultis products and the new Joint Venture. The new collaboration in China allows Evultis to be up to date on the market situation, and propose the best solutions for its partners.

Evultis 2018

Visit CPhI China Friulchem is glad to meet you at Kerry Hotel - Club Lounge meeting room 2 for presenting its news. Contact us at friulchem@friulchem.com

CPhI Japan is the opportunity to meet the country's industry leaders.This event has been the central platform for international businesses for over ten years, where decision makers from Japan and overseas connect and do business.

Friulchem will attend this important event. Meet us at stand IP-14.

Chinese New Year, also known as the Spring Festival in modern China, often called the Lunar New Year in Asia, is an important Chinese festival celebrated at the turn of the traditional lunisolar Chinese calendar.

Friulchem will attend to CPhI Japan 2018.

CPhI Japan is Japan’s most comprehensive pharma event, which brings together more than 20,000 pharma industry professionals from 55+ countries. A wide range of exhibitors from all pharma areas active in Japan as well as free to attend seminars presented by governmental bodies and other important institutions is what you can find. Hosting exhibitors from ingredients, contract services and biopharma through to technology, packaging and machinery.

Register now for free.

The group Evultis SA – Friulchem S.p.A. started a new collaboration in China that allows it to be up to date on the market situation and to be able to satisfy customers requests promptly.

This way the group will be faster in providing the information to the partners.  

DCAT Value Chain Insights published a new article on Patent Ruling for Rifaximin.

Mexican Institute of Industrial Property (IMPI), the patent and trademark administration body of Mexico, recently dismissed a patent-infringement and unfair competition case filed against Interquim, S.A. de C.V.

Read more

Friulchem S.p.A. has filed FC-Cubes patents in EU, US, BRASIL, AUSTRALIA, and MX. The idea started from it is not easy to administer oral medicines to pets. Many owners try to hide tablets in a piece of meat or cheese to give it to their cat or dog. While for the horses they have to deal mainly with products in powder or paste forms. It rarely works: the animal eats the treat and neglects the tablet. Tablets usually produced by extrusion.

Friulchem identified a different manufacturing method, which allows reaching a chewable matrix with all the benefits presented for the drugs already on the market, but without the limits connected to production by extrusion.

Friulchem technology is based on a compression stage, which shows different advantages compared to extrusion:

• Compression provides full control over the weight of the chewable cube and hence over the quantity of API contained in each unit of the finished product, thereby guaranteeing compliance with treatment;
• By compression the outcome could be obtained in different shapes, from the typical square to new “suggestions” heart, bones, fish-shape).

Additionally, FC-Cubes could be manufactured with higher fat and palatable material content, which leads to perfect appetency (total ingestion by animals even on a repeat basis). The compositions of the matrix developed in Friulchem is high palatable and able to mask also active components which are particularly disliked by the animals.

Friulchem S.p.A. is the beneficiary of contribution from Tender POR FESR 2014-2020. Activity 2.3.a.1 “Assistance in support of technological investments of small and medium-size enterprises (SMI)” – Tender DGR 1898 of 07/10/2016 for project titled TECHNOLOGICAL INNOVATION FOR THE ANALYSIS LABORATORY, financially supported by the European Union, the Republic of Italy and the Autonomous Region of Friuli Venezia Giulia.

The project entails the purchase of two pieces of equipment to be installed in the analysis laboratory. Such devices are needed to carry out analyses on substances or substance compounds. The investment also concerns the purchase of two PCs each to be connected to each device.

Project’s main objectives:

• 10% increase in the laboratory’s production capacity (increase of number of samples to be analyzed within a certain amount of time);
• Increase of the analysis laboratory’s competitiveness, thanks to the availability of a faster and more advanced service;
• Increase of the overall competitiveness of the company within the market.

The project was approved with an admissible cost of € 108,189.60 and we were awarded a financial contribution of € 41,562.28. 

Friulchem S.p.A. è beneficiaria di un contributo a valere sul Bando POR FESR 2014-2020. Attività 2.3.a.1 “Aiuti agli investimenti tecnologici delle PMI” – Bando DGR 1898 del 07/10/2016 con un progetto dal titolo INNOVAZIONE TECNOLOGICA PER IL LABORATORIO DI ANALISI, con il supporto finanziario da parte dell’Unione Europea, dalla Repubblica Italiana e dalla Regione Autonoma Friuli Venezia Giulia.

Il progetto prevede l’acquisto di due apparecchiature specifiche da inserire nel laboratorio di analisi. Tali apparecchiature sono necessarie per la realizzazione di analisi sulle sostanze o su miscele di sostanze. L’investimento riguarda anche l’acquisto di due PC da collegare a ciascuna apparecchiatura.

Obiettivi principali del progetto:

• Incremento della capacità produttiva del laboratorio (incremento del numero di campioni analizzabili per unità di tempo) del 10%;
• Incremento della competitività del laboratorio di analisi offrendo un servizio più avanzato e veloce;
• Incremento della competitività complessiva dell’impresa all’interno del mercato.

Il progetto è stato approvato con una spesa ammessa di € 108.189,60 e ci è stato concesso un contributo di € 41.562,28.

Friulchem S.p.A is installing a new micronization unit at its facility in Vivaro, Italy.

This new installation in the Vivaro plant will allow Friulchem to increase its micronization capacity by 1.8 times current capacity (from 250 kg/day up to 700 kg/day), and it will be operational this autumn.

FC Micronization Technology ensures the products’ particle size homogeneity and stability because it works under highly pure nitrogen flow, thus safeguarding products during the micronization process.

Contact friulchem@friulchem.com for more information.

Read the latest DCAT Value Chain Insights, an information resource from the DCAT.

They are talking about Friulchem and its Rifaximin.

CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, hosts more than 42,000 visiting pharma professionals over three days. 2,500+ exhibitors from 153 countries gather at the event to network and take advantage of more than 150 free industry seminars. Every sector of the pharmaceutical market is represented under one roof, this year in Frankfurt.

Contact friulchem@friulchem.com and meet our team at CPhI Worldwide 2017 to discover our news on human, cosmetic & veterinary divisions.

DCAT Week 2018 is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT) to assist its member companies with their business development objectives.

The pet industry in the US and many other countries is booming.

According to the American Pet Product Association (APPA), Americans spent approximately $58 billion on pet products and services in 2014.